BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation

April 18, 2024

https://www.globenewswire.com/news-release/2024/04/18/2865316/0/en/BioVie-to-Present-Data-Showing-How-NE3107-Potentially-Restores-Homeostasis-via-Specific-Genes-Associated-with-Dementia-Metabolism-and-Inflammation.html

CARSON CITY, Nev., April 18, 2024 (GLOBE NEWSWIRE) — BioVie Inc. (Nasdaq:BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that an oral presentation and poster presentation will be shared at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit to be held in Boston, Massachusetts April 23-25.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.